id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-269344-7ik9e5m4	Gerussi, Alessio	Coronavirus Disease 2019 (COVID‐19) in autoimmune hepatitis: a lesson from immunosuppressed patients	2020-06-09		.txt	text/plain	1925	107	45	Our aim was to describe the clinical course of immunosuppressed autoimmune hepatitis (AIH) patients during coronavirus disease 2019 (COVID‐19) infection in Italy. METHODS: Our study is a case series of AIH patients treated with immunosuppression, who tested positive for SARS‐CoV‐2 in March 2020 during outbreak of COVID‐19. Two other patients (patient 2 and 4) had an acute onset of AIH and were under high-dose steroids, as per induction protocol, at the time of SARS-CoV-2 infection. Moreover, we believe that pre-emptive strategies of reduction of immunosuppression during COVID-19 can be potentially harmful, as suggested by the disease course of patient 9 that self-stopped steroid treatment and relapsed after SARS-CoV-2 infection. The lack of a control group of non-AIH patients and the nature of this manuscript (case series) do not allow us to draw conclusions regarding the possible association between chronic treatment with thiopurines and the risk of developing COVID-19.	./cache/cord-269344-7ik9e5m4.txt	./txt/cord-269344-7ik9e5m4.txt